Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-705498 in rectal hypersensitivity and irritable bowel syndrome
2006-002632-21Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rectal hyperalgesia (RH), proctalgia and irritable bowel syndrome (IBS) comparing SB-705498 with Placebo (2 arms). Primary endpoint: Rectal pain to distension. Started Oct 2006; status: completed.
02
Drugs
SB-705498
03
Conditions
rectal hyperalgesia (RH)proctalgiairritable bowel syndrome (IBS)
Beyond the preview
Go deeper on 2006-002632-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002632-21.